Anno 2005 - Vol 13 - N° 3 - AIDA

ns
s.
ns
c.
et:
O
'"C
:::l
CI)
ns
- O
'"C
C
ns
e_
Luglio- errembre 2005
Numero 3
28) Lillis Pl, Coleman WP: Liposuction for treatment ofaxiUary hyperhidrosis. Dermatolol Clin 1990;
8: 479-482.
29) Skoog T, Thyresson N. Hyperhidrosis of the axillae. A method of surgical treatment. Acta Chir
cand 1962; 124: 531-538.
30) Herbst F, Plas EG, Fugger R, Fritsch A: Endoscopic thoracic sympathectomy for primary hyperhidrosis.
Ann. urgo 1994; 220: 88-96.
31) Park DH, Kim TM, Han DG, Ahn KY. A comparative scudy of the surgical treatment ofaxillary
osmidrosis by instrument, manual, and combined subcutaneolls shaving procedures. Ann Plast Surg
1998; 41: 488-497.
32) Naumann M, Hofmann U, Bergmann I, Hamm H , Toyka KY, Reiners K.. Focal hyperhidrosis:
effective treatment with intracutaneous botulinum toxin. Arch Dermatol 1998; 134: 301-304.
33) aid S, Meshkinpour A, Carruthers A, Carruthers]. Botulinum toxin: its expanding role in dermatology
and esthetics. Am l Clin Dermatol 2003: 4 (9): 609-616.
34) aumann M, Lowe l, Kumar CR, Hamm H; Hyperhidrosis Clinical Investigators Group.
Boculinum toxin rype a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a
prospective scudy. Arch Dermatol. 2003; 139 (6): 731-736.
35) Parsons 1M. Transient acantholytic dermatosis (Grover's disease): a global perspective. l Am Acad
Dermatol 1996; 35: 653-666.
36) Grover's disease: 34 years ono Quirk Cl, Heenan Pl. Australasian lournal ofDermatology 2004: 45:
83-88.
37) Hayashi H. Treatment of Grover' s disease wi th tacalcitol. Clin Exp Dermatol 2002; 27: 160-16l.
38) Helfman Rl. Grover's disease treated with isotretinoin. l Am Acad Dermatol 1985; 12: 981-984.